October 11, 2013
The full Federal Circuit on Friday declined to review a ruling that two Cordis Corp. and Wyeth Pharmaceuticals Inc. patents covering a drug used in stents are invalid, turning aside the companies' claim that the ruling "will cast doubt upon the validity of large numbers of existing patents."